Humanigen Inc (HGENQ)

[cowtown jay]

"The Creditors’ Committee initially objected to the sale to Taran ..."

"On May 20, 2024, the Reporting Persons announced that in light of recent developments at the Issuer, they have determined to withdraw their preliminary proxy statement and campaign against the re-election of the Class II directors..."

The two above statements apply to Humanigen/Taran, and to Novavax/Sanofi, respectively. They both represent an abrupt about-face from the opposition the creditors and investors had towards Humanigen and Novavax.

That's completely understandable. Humanigen's Unsecured Creditors were excited about the Asset Purchase Agreement (APA) in regards to monetizing Milestone Events, because that would be based on regulatory approval.

https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1075977&projectCode=HUM&docketNumber=235&source=DM

And Novavax investors were excited about the removal of the company's going concern status, based on the co-exclusive licensing agreement they obtained with Sanofi.

To see some of the biggest stakeholders in Humanigen and Novavax abruptly cease their opposition to the directions of these two companies, foretells their unfolding success, which has been all too obvious to some of us, for quite some time.